Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action
Open Access
- 18 June 2021
- Vol. 9 (6), 667
- https://doi.org/10.3390/vaccines9060667
Abstract
The ultimate goal for vaccination is the generation of a safe and effective immune response that protects against diseasesThis publication has 11 references indexed in Scilit:
- The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in MiceVaccines, 2021
- Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and FormulationVaccines, 2021
- Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in MiceVaccines, 2021
- Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal VaccinesVaccines, 2021
- Natural and Synthetic Saponins as Vaccine AdjuvantsVaccines, 2021
- Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune ResponsesVaccines, 2020
- Repurposing of Miltefosine as an Adjuvant for Influenza VaccineVaccines, 2020
- Combination of Innate Immune Modulators as Vaccine Adjuvants in MiceVaccines, 2020
- The Age of Cyclic Dinucleotide Vaccine AdjuvantsVaccines, 2020
- Adjuvant Activity of Synthetic Lipid A of Alcaligenes, a Gut-Associated Lymphoid Tissue-Resident Commensal Bacterium, to Augment Antigen-Specific IgG and Th17 Responses in Systemic VaccineVaccines, 2020